Our Partners

The Government of Ontario (Ministry of Research, Innovation and Science) announced the establishment of the OIRM with $3M in funding on November 25, 2014. The OIRM is organized as a partnership among the Government of Ontario, Ontario’s academic research centres, the Centre for Commercialization of Regenerative Medicine and health charities.

The Ontario Advantage

• World-leading scientific discoveries in stem cell and regenerative medicine with Canada ranking third in the world for impact factor
• Collaborative network of over 150 research programs including stem cell biologists, tissue engineers and translational clinicians
• Multidisciplinary Disease Challenge Teams already focused on clinical translation
• Established commercialization entity with strong links to international industry
• World-class clinical infrastructure and expertise for implementing cell therapy trials (phase I-III)
• Process for creating and incubating well-funded spin-offs into the community
• Favourable philanthropic community and public opinion
• Thriving international partnerships with China and Japan

The Ontario Opportunity

• Public-private consortium creating international cell therapy manufacturing hub
• Creation of companies that:
  • Set-up shop in Ontario
  • Manufacture cells
  • Participate in clinical trials
  • Produce affordable therapies that are reimbursable
  • Create jobs that stick
• Healthcare system poised to be an early adapter of new therapies
• Major centre for international clinical trials in stem cell and regenerative medicine